Ask AI

Reviewing the Role of VEGF-Targeting Agents in the Treatment of GI Cancers

In this educational activity an expert panel comprising Jordi Bruix MD Yelena Y. Janjigian MD John L. Marshall MD and Neeta Somaiah MD discuss the most recent clinical data informing the optimal use of VEGF-targeted therapies in the care of patients with advanced CRC HCC gastric/GEJ cancer and GIST.

Share

Program Content

No activities added yet

Supporters

This activity is supported by an educational grant from

Bayer Healthcare Pharma